Latest Regenerative October 1, 2025 News

Klotho Neurosciences to Acquire Turn Biotechnologies Assets, Secures $300 Million Deal

Klotho Neurosciences expands into cellular reprogramming with a planned Turn Biotechnologies acquisition and significant pharma partnership.

Gallant Advances First Ready-to-Use Feline Stem Cell Therapy Toward FDA Approval

The therapy is getting close to conditional approval for our feline friends.

Cell X Technologies and BioLamina Partner on induced pluripotent stem cell (iPSC) Standardization

The collaboration aims to streamline iPSC manufacturing by combining automation with standardized reagents for reproducible, scalable cell therapy processes.

QC Kinetix Revamps Brand and Operations, Improves Average Clinic Profitability by 22.51%

Following a year-long overhaul, QC Kinetix reports improved clinic performance and profitability as it restarts franchise expansion plans.
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe